Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1053 | 997 | 1091 | 1121 | 1462 | 1812 |
Fund Return | 5.32% | -0.3% | 9.12% | 3.88% | 7.9% | 6.12% |
Place in category | 110 | 84 | 95 | 42 | 89 | 97 |
% in Category | 46 | 36 | 43 | 23 | 50 | 81 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
James Alpha Global Real Estate InvI | 251.88M | 8.97 | -3.04 | 5.27 | ||
James Alpha Global Real Estate InvA | 47.22M | -4.11 | -3.71 | 4.27 | ||
Saratoga Large Capitalization Growi | 31.14M | 24.83 | 9.29 | 14.90 | ||
Saratoga Health Biotechnology Inst | 6.99M | 0.03 | 6.28 | 7.00 | ||
Saratoga Large Capitalization Growa | 2.54M | 12.00 | 12.59 | 13.72 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Health Care Adm | 43.27B | 17.24 | 6.89 | 10.05 | ||
Fidelity Select Health Care | 10.35B | 13.63 | 0.73 | 9.96 | ||
T. Rowe Price Health Sciences | 9.3B | 16.59 | 0.90 | 11.27 | ||
Vanguard Health Care Inv | 7.8B | 17.21 | 6.84 | 9.99 | ||
T. Rowe Price Health Sciences I | 6.17B | 16.68 | 1.02 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Regeneron Pharma | US75886F1075 | 5.50 | 1,039.96 | +0.85% | |
Amgen | US0311621009 | 5.10 | 319.10 | +1.99% | |
McKesson | US58155Q1031 | 5.01 | 479.06 | -0.02% | |
Tenet Healthcare | US88033G4073 | 4.90 | 164.94 | -1.65% | |
Cencora Inc | US03073E1055 | 4.87 | 223.88 | +0.20% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Buy | Buy |
Technical Indicators | Sell | Strong Buy | Strong Buy |
Summary | Sell | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review